E-Book | January 18, 2023

Continuous Manufacturing Progress & Pitfalls

Source: Bioprocess Online
23_01_BPO_ContMfgEbook_450x300

Here are the latest takes on both the progress and the pitfalls of continuous manufacturing adoption in biopharma, exclusively from Bioprocess Online

  • Learn what's working, what's not, and why in a collaborative report authored by Richard Chen (Eli Lilly and Company), Chris Hwang (Transcenta Holding Ltd.), Kelvin Lee (NIIMBL), Andrew Zydney (The Pennsylvania State University), and John F. Kokai-Kun (The United States Pharmacopeia).
  • Wonder how continuous manufacturing compares with batch processing in terms of environmental impact and resource consumption? Get answers from John F. Kokai-Kun (The United States Pharmacopeia) in a comprehensive two-parter on the topic.
  • Find out what went wrong for biopharma continuous manufacturing pioneer Parrish Galliher, now an independent bioprocess consultant, and learn how to avoid making the same mistakes. 
  • Is your regulatory effort going global, or planning to? Catch up on the latest (final?) Q13 guidance from ICH with Nathan Parker, Principal Consultant, Parker Biopharmaceutical Consulting.

Where else can you get such a complete and current take on continuous manufacturing in biopharmaceutical environments, all in one package, from seven of the leading minds on the topic?

VIEW THE E-BOOK!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online